Eli Lilly and Company (LLY)
Your Dashboard
Displaying LLY Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 1.246B
- Accounts Receivable 3.931B
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 0.7398
- Beneish M-Score Pro
- Beta Pro
- Book Value 14.82B
- Book Value per Share 12.77
- Capital Expenditures 130.70M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing -2.057B
- Cash Financing TTM -3.713B
- Cash Investing -652.30M
- Cash Investing TTM -5.436B
- Cash Operations 852.50M
- Cash Operations TTM 6.911B
- Cash and Equivalents 4.122B
- Cash and ST Investments 4.925B
- Current Ratio 1.923
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.3652
- Dividend
- Dividend Yield 4.84%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share 0.91
- Earnings Per Share Growth -4.21%
- Earnings Per Share TTM 3.86
- Earnings Yield 9.41%
- Effective Tax Rate TTM Pro
- Enterprise Value 49.22B
- Expenses 4.591B
- Expenses TTM 19.75B
- Free Cash Flow 721.80M
- Free Cash Flow TTM 6.235B
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin 78.62%
- Gross Profit TTM 18.96B
- Income from Cont. Ops Pro
- Interest Expense 0.00
- Interest Income
- Inventories 2.424B
- KZ Index Pro
- Liabilities 17.42B
- Long Term Debt 5.414B
- Market Cap 47.58B
- Net Income 1.011B
- Net Income TTM 4.303B
- Net PP&E 7.755B
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio 10.62
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 41.00
- Price / Book Value 3.210
- Price / Sales Ratio 1.978
- Price / Tangible Book Value Pro
- Profit Margin 18.05%
- R&D Expense 1.152B
- Receivables Turnover 5.754
- Retained Earnings 15.91B
- Retained Earnings Growth 15.39%
- Return on Assets 13.17%
- Return on Equity 30.04%
- Return on Invested Capital Pro
- Revenue Growth -4.06%
- Revenue Per Share TTM 20.72
- Revenues 5.602B
- Revenues TTM 24.05B
- SG&A Expense 1.848B
- Shareholders Equity 14.82B
- Shares Outstanding 1.160B
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 32.24B
- Total Return Price 41.00
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these LLY related companies
LLY News
Boehringer Ingelheim, Lilly (LLY) Say Linagliptin Showed Significant Improvement in HbA1c in Phase 3
May 24, 9:02AM Street Insider
May 24, 9:02AM Street Insider
Pharma has been a place to hide in pullback, but there are many fewer names that look healthy. $PFE still holding, $LLY looks ready to drop
about 11 days ago by harmongreg
about 11 days ago by harmongreg
$PFE $LLY $GSK So this is the condition some drug commercials warned us about! And we thought they were kidding. http://stks.co/3q2n
about 15 days ago by laughing_stock
about 15 days ago by laughing_stock
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 15 days ago by abubnic
about 15 days ago by abubnic
Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer
May 14, 9:00AM PR Newswire
May 14, 9:00AM PR Newswire
Ex-Dividend Stocks: DuPont, AK Steel http://stks.co/3lBo My story via @TheStreet $DD $AKS $LLY $BTU $EXC $HLF #ExDividend #Dividend
about 20 days ago by azendrian
about 20 days ago by azendrian
$LLY MACDBullish Trend Chart pat UpTrend RSI Bullish Up/Down vol pat under Accum 50/200d MA Bullish Support 39.47 above Resis 40.12 Bullis
about 24 days ago by MACDaddy
about 24 days ago by MACDaddy
Stock Trading Ideas for the Week of 5/7/12 http://stks.co/3gjx via @alphatrends $LLY $ARBA $MM
about 24 days ago by StockTwits
about 24 days ago by StockTwits
FDA Approves Amyvid for Alzheimer’s Diagnosis. $LLY http://stks.co/3ZNn
about 31 days ago by abubnic
about 31 days ago by abubnic
News related to $LLY, currently +0.3% since open: 'ImmunoGen fiscal 3Q loss widens as expenses rise' http://stks.co/3YQK
about 33 days ago by TradeBot
about 33 days ago by TradeBot
$LLY another strong healthcare name trying to breakout. Low volatility also vs SPX. $XLV http://stks.co/3Xg3
about 34 days ago by tradewithpete
about 34 days ago by tradewithpete
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| LLY | 41.00 | -0.30 | -0.73% | 47.92B |
| LLTC | 29.09 | -0.33 | -1.12% | 6.737B |
| LLNW | 2.74 | -0.03 | -1.08% | 288.69M |
| LLL | 67.63 | -0.27 | -0.40% | 6.715B |
| LLEN | 1.59 | -0.10 | -5.92% | 55.60M |
| LL | 29.40 | -0.58 | -1.93% | 840.04M |
| LKQX | 36.28 | +0.75 | +2.11% | 5.345B |
| KERX | 1.65 | -0.05 | -2.94% | 120.73M |
| KEQU | 8.25 | -0.02 | -0.24% | 21.28M |
| KEP | 9.40 | -0.12 | -1.26% | 12.22B |
